TGTX
Tg Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.90 / 10
Netural
Analyst sentiment is neutral with a 50% Buy and 50% Neutral split from two analysts, but historical win rates are poor (0.0%). Fund flow is robust (score 7.8/10) with positive Small and Medium inflows, yet overall and Large inflows trend negative. Options activity on 14 Jan showed a significant call purchase spike, aligning with the broader neutral-to-cautious tone. Together, the data suggest limited conviction from both analysts and large funds.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-02
InstitutionJP Morgan
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for TGTX?
- TGTX holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.90/10 (Netural).
